Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection

[1] Dall’Era MA(2012)Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 976-983

[2] Albertsen PC(2013)Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis BJU Int 111 437-450

[3] Bangma C(2015)Long-term follow-up of a large active surveillance cohort of patients with prostate cancer J Clin Oncol 33 272-277

[4] Cooperberg MR(2015)Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer J Clin Oncol 33 3379-3385

[5] Ramakrishna NR(2014)The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance J Urol 191 660-664

[6] Duff SB(2015)Compliance rates with the prostate cancer research international active surveillance (PRIAS) protocol and disease reclassification in noncompliers Eur Urol 68 814-821

[7] Klotz L(2011)Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2185-2190

[8] Vesprini D(2013)Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens Prostate 73 778-787

[9] Sethukavalan P(2009)Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2274-2278

[10] Jethava V(2010)Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting Prostate Cancer Prostatic Dis. 13 71-77

[1] Dall’Era MA(2012)Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 976-983

[2] Albertsen PC(2013)Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis BJU Int 111 437-450

[3] Bangma C(2015)Long-term follow-up of a large active surveillance cohort of patients with prostate cancer J Clin Oncol 33 272-277

[4] Cooperberg MR(2015)Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer J Clin Oncol 33 3379-3385

[5] Ramakrishna NR(2014)The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance J Urol 191 660-664

[6] Duff SB(2015)Compliance rates with the prostate cancer research international active surveillance (PRIAS) protocol and disease reclassification in noncompliers Eur Urol 68 814-821

[7] Klotz L(2011)Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2185-2190

[8] Vesprini D(2013)Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens Prostate 73 778-787

[9] Sethukavalan P(2009)Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2274-2278

[10] Jethava V(2010)Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting Prostate Cancer Prostatic Dis. 13 71-77